Susan I. Vear

Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy

Dana C. Crawford, Erica A. Bowton, Dan M. Roden, 2015, PloS one.

A Model of Care for Childhood Cancer Survivors That Facilitates Research

M. Hudson, Susan I. Vear, Sally Wiard, 2004, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population

G. Ayers, C. Stein, S. L. Driest, 2014, British journal of haematology.

Genotype and risk of major bleeding during warfarin treatment.

B. Gage, D. Roden, J. Denny, 2014, Pharmacogenomics.

Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

J. Opferman, R. Norris, C. Mullighan, 2019, Blood.

Warfarin pharmacogenomics in children

R. Ho, Susan I. Vear, C. M. Stein, 2013, Pediatric blood & cancer.

t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature

H. Frangoul, S. Borinstein, R. Ho, 2013, Case reports in hematology.

Gene-Based Dose Optimization in Children.

S. V. Van Driest, J. Bishop, L. Ramsey, 2020, Annual review of pharmacology and toxicology.

CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis

Kaitlyn Shaw, B. Carleton, M. Loriot, 2019, The Pharmacogenomics Journal.

Case of Severe Cardiotoxicity in a Pediatric Patient After Fluorouracil Administration.

J. Stanek, Susan I. Vear, N. Yeager, 2019, JCO precision oncology.